Home Sectors Healthcare Stock Under Review: AngioDynamics (NASDAQ: ANGO)

Stock Under Review: AngioDynamics (NASDAQ: ANGO)

5
0
SHARE

AngioDynamics is part of the healthcare sector and medical instruments and equipment industry. The company CEO is James C. Clemmer. AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Previous Intraday Trading Performance:

The ANGO stock showed a previous change of -1.87% with an open at 20.29 and a close of 19.97. It reached an intraday high of 20.43 and a low of 19.93.

SeekingAlpha:  AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference – Slideshow

Liquidity:

The stock has a market cap of $741.3m with 37.1m shares outstanding, of which the float is 33.4m shares. Trading volume reached 185,813 shares compared to its average volume of 245,280 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, AngioDynamics shares returned -3.99% and in the past 30 trading days it returned -11.01%. Over three months, it changed -11.56%. In one year it has changed 19.30% and within that year its 52-week high was 24.49 and its 52-week low was 15.16. ANGO stock is 31.73% above its 52 Week Low.

Our calculations show a 200 day moving average of 19.76 and a 50 day moving average of 22.26. Currently ANGO stock is trading 1.06% above its 200 day moving average and may be a good opportunity to buy.

SeekingAlpha:  AngioDynamics (ANGO) Presents At Cantor Global Healthcare Conference – Slideshow

Earnings:

The last annual fiscal EPS for the company was reported at 0.44 that ended on 31st of May 2018, which according to the previous close, that is a PE of 45.39. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.20. The TTM EPS is 0.72, which comes to a TTM PE of 27.74.

The following are the last four quarter reported earnings per share:
08-31-2018:  0.16
05-31-2018:  0.20
02-28-2018:  0.25
11-30-2017:  0.16

Base on our calculations, the intrinsic value per share is 21.18, which means it is possibly undervalued and has a margin of safety of 5.72%

Indicators to Watch:

Short-interest is 2,564,851, which is 6.91% of shares outstanding. The short-interest ratio or days-to-cover ratio is 11.21. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.

The current calculated beta is 0.80

Business Wire:  American Vanguard Declares Quarterly Dividend

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 3.03%, return on assets is 2.31%, profit margin is 4.68%, price-to-sales is 2.19 and price-to-book is 1.39.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 3  :Past Performance Score
 6  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.